Antimicrobial agent use in small animals what are the prescribing practices, use of PK-PD principles, and extralabel use in the United States? - PubMed (original) (raw)
Review
. 2021 Mar;44(2):238-249.
doi: 10.1111/jvp.12921. Epub 2020 Oct 23.
Affiliations
- PMID: 33098148
- DOI: 10.1111/jvp.12921
Review
Antimicrobial agent use in small animals what are the prescribing practices, use of PK-PD principles, and extralabel use in the United States?
Mark G Papich. J Vet Pharmacol Ther. 2021 Mar.
Abstract
In this review, the availability and deficiencies of current antimicrobial agents for companion animals in the United States are described. Although several active agents are FDA-approved for small animals, there are many unmet needs. These needs are greatest for cats, for the treatment of antibiotic drug-resistant infections, and to treat new or emerging pathogens that were not considered on older labels. The older agents approved before 1997 are often outdated, unavailable, or have inaccurate labeling. Subsequently, veterinarians treat dogs and cats with many unapproved antimicrobial agents that are licensed for human use. Although these drugs may be effective, there are also concerns that this use can produce drug-resistant bacteria that may be a public health risk. Although this concern is real, there is also evidence that any antimicrobial use in small animals can produce resistant fecal bacteria and stewardship principles should aim at reducing any unnecessary antibiotic use. This could be accomplished by avoiding some of the older, ineffective, or outdated agents described in this paper. There is a need for incentives to approve new agents that will be more appropriate for treating infections in companion animals without increasing the risk of drug-resistant bacteria that could potentially be transferred to humans and the environment and create a public health risk.
Keywords: antibacterial; antibiotics; antiinfective; companion animal; pharmacokinetics.
© 2020 John Wiley & Sons Ltd.
Similar articles
- Assessing Illinois companion animal veterinarians' antimicrobial prescription practices and the factors that influence their decisions when treating bacterial infections in dogs and cats.
Yudhanto S, Reinhart JM, de Souza CP, Gochenauer A, Sander WE, Hung CC, Maddox CW, Varga C. Yudhanto S, et al. Zoonoses Public Health. 2024 Dec;71(8):911-924. doi: 10.1111/zph.13172. Epub 2024 Jul 23. Zoonoses Public Health. 2024. PMID: 39044541 - Effect of an antimicrobial stewardship intervention on the prescribing behaviours of companion animal veterinarians: A pre-post study.
Walker B, Sánchez-Vizcaíno F, Barker EN. Walker B, et al. Vet Rec. 2022 Jun;190(12):e1485. doi: 10.1002/vetr.1485. Epub 2022 Feb 24. Vet Rec. 2022. PMID: 35202485 - Population wide assessment of antimicrobial use in dogs and cats using a novel data source - A cohort study using pet insurance data.
Hardefeldt LY, Selinger J, Stevenson MA, Gilkerson JR, Crabb H, Billman-Jacobe H, Thursky K, Bailey KE, Awad M, Browning GF. Hardefeldt LY, et al. Vet Microbiol. 2018 Nov;225:34-39. doi: 10.1016/j.vetmic.2018.09.010. Epub 2018 Sep 18. Vet Microbiol. 2018. PMID: 30322530 - Pharmacokinetics, pharmacodynamics and therapeutics of pradofloxacin in the dog and cat.
Lees P. Lees P. J Vet Pharmacol Ther. 2013 Jun;36(3):209-21. doi: 10.1111/jvp.12036. Epub 2013 Feb 14. J Vet Pharmacol Ther. 2013. PMID: 23406008 Review. - Principles of antimicrobial therapy.
Whittem T, Gaon D. Whittem T, et al. Vet Clin North Am Small Anim Pract. 1998 Mar;28(2):197-213. doi: 10.1016/s0195-5616(98)82001-9. Vet Clin North Am Small Anim Pract. 1998. PMID: 9556845 Review.
Cited by
- Potential Causes of Spread of Antimicrobial Resistance and Preventive Measures in One Health Perspective-A Review.
Endale H, Mathewos M, Abdeta D. Endale H, et al. Infect Drug Resist. 2023 Dec 8;16:7515-7545. doi: 10.2147/IDR.S428837. eCollection 2023. Infect Drug Resist. 2023. PMID: 38089962 Free PMC article. Review. - The Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine, a Complex Phenomenon: A Narrative Review.
Caneschi A, Bardhi A, Barbarossa A, Zaghini A. Caneschi A, et al. Antibiotics (Basel). 2023 Mar 1;12(3):487. doi: 10.3390/antibiotics12030487. Antibiotics (Basel). 2023. PMID: 36978354 Free PMC article. Review. - Sensing Levofloxacin with an RNA Aptamer as a Bioreceptor.
Kramat J, Kraus L, Gunawan VJ, Smyej E, Froehlich P, Weber TE, Spiehl D, Koeppl H, Blaeser A, Suess B. Kramat J, et al. Biosensors (Basel). 2024 Jan 22;14(1):56. doi: 10.3390/bios14010056. Biosensors (Basel). 2024. PMID: 38275309 Free PMC article. - An assessment and characterization of pharmaceuticals and personal care products (PPCPs) within the Great Lakes Basin: Mussel Watch Program (2013-2018).
M A E, K K, N F, E D, M R, A F, S R, A L, K, H B, A J, E J. M A E, et al. Environ Monit Assess. 2024 Mar 5;196(4):345. doi: 10.1007/s10661-023-12119-3. Environ Monit Assess. 2024. PMID: 38438687 Free PMC article. - Impacts of the COVID-19 pandemic on antimicrobial use in companion animals in an academic veterinary hospital in North Carolina.
Jolley A, Love W, Frey E, Lanzas C. Jolley A, et al. Zoonoses Public Health. 2023 Aug;70(5):393-402. doi: 10.1111/zph.13040. Epub 2023 Apr 7. Zoonoses Public Health. 2023. PMID: 37029504 Free PMC article.
References
REFERENCES
- Ambrose, P. G. (2006). Monte Carlo simulation in the evaluation of susceptibility breakpoints: Predicting the future: Insights from the society of infectious diseases pharmacists. Pharmacotherapy, 26(1), 129-134. https://doi.org/10.1592/phco.2006.26.1.129
- Ambrose, P. G., Bhavnani, S. M., & Owens, R. C. (2003). Clinical pharmacodynamics of quinolones. Infectious Disease Clinics, 17(3), 529-543. https://doi.org/10.1016/S0891-5520(03)00061-8
- Ambrose, P. G., Bhavnani, S. M., Rubino, C. M., Louie, A., Gumbo, T., Forrest, A., & Drusano, G. L. (2007). Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore. Clinical Infectious Diseases, 44(1), 79-86.
- AMDUCA (1994). Retrieved from https://www.fda.gov/animal-veterinary/acts-rules-regulations/animal-medi...
- Beck, K. M., Waisglass, S. E., Dick, H. L., & Weese, J. S. (2012). Prevalence of meticillin-resistant Staphylococcus pseudintermedius (MRSP) from skin and carriage sites of dogs after treatment of their meticillin-resistant or meticillin-sensitive staphylococcal pyoderma. Veterinary Dermatology, 23(4), 369. https://doi.org/10.1111/j.1365-3164.2012.01035.x
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous